Reproductive Health and Contraception
14 works
Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan
Sheila Raghavan, Tamar Tsereteli, A. Kamilov +5
ArticleReproductive Health and ContraceptionThe European Journal of Contraception & Reproductive Health Care20130 citationsABI